Closure of USFDA inspection at Zydus' API Unit 1 at Ankleshwar, Gujarat

The USFDA conducted a surveillance inspection at the group's API Unit 1, located at Ankleshwar in Gujarat. The inspection was conducted from March 10th to 14th, 2025. The inspection concluded with NIL observations.

USFDA Inspection at Alkem Laboratories’ Bioequivalence Center located at Taloja

US FDA had conducted a Bioresearch Monitoring (BIMO) inspection at Alkem Laboratories Limited's Bioequivalence Center located at Taloja, Maharashtra from 10th March, 2025 to 13th March, 2025. At the end of the inspection, no Form 483 was issued.

Alkem Medtech to acquire 100% stake of Bombay Ortho

Alkem Medtech Private Limited, a wholly owned subsidiary of Alkem Laboratories Limited in India intends to acquire 100% stake of M/s. Bombay Ortho Industries Private Limited. A Share Purchase and Share Subscription Agreement has been executed, amongst Alkem Medtech and Bombay Ortho.

Relonchem receives marketing authorization for Baclofen 10 mg Tablets from UK MHRA

Marksans Pharma Limited’s wholly owned subsidiary in the UK, Relonchem Limited receives marketing authorization for the product Baclofen 10 mg Tablets from UK MHRA. Marksans Pharma Limited  hereby announces that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization for the product Baclofen 10 mg Tablets from UK MHRA.